Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

证券代码：000881 证券简称：中广核技 公告编号：2025-056 中广核核技术发展股份有限公司 关于持股 5%以上股东部分股份将被司法拍卖的进展 公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别风险提示： 截至本公告日，中国大连国际经济技术合作集团有限公司（以下简称"国 合集团"）持有本公司 118,914,273 股，占公司总股本的 12.58%，为公司持股 5%以上股东而非控股股东，亦非公司控股股东的一致行动人，其所持公司部分 股份被司法拍卖不会影响公司的正常生产经营。 2025 年 10 月 28 日，中广核核技术发展股份有限公司（以下简称"公司"） 在 《 中 国 证 券 报 》 《 上 海 证 券 报 》 《 证 券 时 报 》 和 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露了《关于持股 5%以上股东部分股份将被司法拍 卖的公告》（公告编号 2025-050）。近日，公司接到国合集团通知，根据大连高 新技术产业园区人民法院的《拍卖通知书》，国合集团所持有本公司的 2,750 万 股股份将于 202 ...

中广核技公告，持股5%以上股东国合集团所持有公司的2750万股股份将于2026年1月22日至2026年1月 23日止在京东网拍卖，占其所持股份比例的23.13%，占公司总股本的2.91%。国合集团不是公司的控股 股东，其所持股份被司法拍卖不会影响公司的正常生产经营。 ...

【财经日历】 日本央行公布利率决议 摩尔线程MUSA开发者大会(北京，12/19-12/20) 富时中国A50指数季度调整于收盘后生效 美国11月核心PCE物价指数年率 首届进博优品交易会(上海，12/19-12/21) 第五届碳中和博鳌大会(12/19-12/20) 新股申购： | 名称 | 现价 | | --- | --- | | 道琼斯工业平均 | | | 纳斯达克指数 | 23006.36c 313.04 1.38% | | 标普500 | 6774.76 53.33 | 当地时间周四，美股主要股指集体收高。截至收盘，道指涨0.14%，标普500指数涨0.79%，纳指涨 1.38%。小盘股同步走强，罗素2000指数上涨0.62%。 科技股成为当日市场的主要推动力。美光科技股价大涨10.2%，公司给出的季度利润指引接近分析师预 期的两倍，显示人工智能相关需求依旧强劲，带动费城半导体指数上涨2.6%。 大型科技股普遍走高。特斯拉上涨3.45%，英伟达上涨1.87%，博通上涨1.18%，微软上涨1.65%，Meta 上涨2.32%，亚马逊上涨2.48%；AlphabetA股和C股分别上涨1.93%和1.91 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-055 中广核核技术发展股份有限公司 关于董事会换届选举的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会将于 2026 年 1 月任期届满。为顺利完成董事会的换届选举（以下简称"本次换届选举"）， 公司董事会根据《中华人民共和国公司法》《上市公司独立董事管理办法》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》《公司章 程》等有关规定，现将十一届董事会董事候选人提名、本次换届选举程序、董事 任职资格等事项公告如下： 一、董事候选人提名 1、非独立董事候选人提名 公司董事会及本公告发布之日单独或合并持有公司 1%以上股份的股东有权 向第十届董事会提名推荐第十一届董事会非独立董事候选人。单个提名人提名的 非独立董事人数不得超过本次拟选的非独立董事总人数。 2、独立董事候选人提名 公司董事会及本公告发布之日单独或合并持有公司 1%以上股份的股东有权 向第十届董事会提名推荐第十一届董事会独立董事候选人。单 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-054 关于持股 5%以上股东股份被冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别风险提示： 1.截至本公告日，中国大连国际经济技术合作集团有限公司（以下简称"国合集团"） 持有本公司 118,914,273 股，占公司总股本的 12.58%，为公司持股 5%以上股东而非控股股 东，亦非公司控股股东的一致行动人，其所持公司股份被司法冻结不会影响公司的正常生 产经营。 2.截至本公告日，国合集团持有公司股份累计被冻结 118,914,273 股，占其所持有的公 司股份的 100.00%，占公司总股本的 12.58%。 中广核核技术发展股份有限公司（以下简称"公司"）于 2025 年 12 月 17 日接到持股 5%以上股东国合集团函告，获悉国合集团所持有本公司的部分股份 被司法再冻结及轮候冻结，具体事项如下： 一、国合集团持有公司股份被冻结的基本情况 | 股东名 称 | 是否为控 股股东或 第一大股 | 本次冻结股 | 占其 所持 | 占公 司总 | 是否为限 售股及限 | 起始 ...

Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (CGN Tech) announced that as of December 17, 2025, a significant shareholder, Guohe Group, has had part of its shares judicially frozen due to a financial loan dispute [1] Group 1: Shareholder Information - Guohe Group holds 119 million shares of CGN Tech, representing 12.58% of the total share capital [1] - The total number of frozen shares is 119 million, which accounts for 100% of Guohe Group's holdings in CGN Tech and 12.58% of the total share capital [1] Group 2: Legal and Operational Impact - The shares frozen are related to the lock-up shares post-initial public offering (IPO) [1] - The freezing of shares is executed by the Dalian High-tech Industrial Park People's Court, but it does not affect the normal production and operation of CGN Tech [1]

Group 1 - The mechanical sector has shown strong performance in 2025, with the Shenwan Mechanical Equipment Index rising by 36.11%, outperforming the Shanghai Composite Index by 19.74 percentage points and the Shenzhen Component Index by 8.78 percentage points [4][16][19] - In the first three quarters of 2025, the mechanical industry reported revenues of 15,135.34 billion yuan, a year-on-year increase of 7.35%, and a net profit attributable to shareholders of 1,080.76 billion yuan, up 16.80% year-on-year [4][22][27] - The public fund allocation ratio for the mechanical equipment sector increased by 0.25 percentage points in Q3 2025 compared to Q3 2024, indicating improved fundamentals and positive policy impacts [29] Group 2 - The equipment manufacturing industry has maintained export resilience, with significant growth in new overseas markets. From January to October 2025, the export delivery value of general equipment, specialized equipment, and transportation equipment reached 6,173.20 billion yuan, 5,319.30 billion yuan, and 4,124 billion yuan respectively, with year-on-year growth rates of 5.5%, 9.3%, and 24.20% [5][33][36] - The overseas sales of engineering machinery continued to grow, with a year-on-year increase of 11.84% in export value from January to October 2025, driven by technological innovation and diversified market strategies [37][41] - The motorcycle industry has established a strong competitive advantage in overseas markets, with exports reaching 1,101.85 million units and 7.278 billion USD in value from January to October 2025, reflecting a year-on-year increase of 22.28% and 28.2% respectively [42][43] Group 3 - The emergence of new manufacturing scenarios signifies a profound transformation from "single technology upgrades" to "systematic ecological restructuring," enhancing production efficiency, product quality, and innovation capabilities [5][46] - Human-shaped robots are expected to address customization challenges in traditional manufacturing, with a market space projected to expand significantly as they transition from industrial applications to household use [47][54] - The intelligent logistics equipment market in China is expected to grow rapidly, with a projected market size of 1,261 billion yuan in 2025, driven by advancements in IoT and AI technologies [64][72]

Market Overview - The chemical products sector increased by 0.28% on December 12, with Qiaoyuan Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3889.35, up 0.41%, while the Shenzhen Component Index closed at 13258.33, up 0.84% [1] Top Gainers in Chemical Sector - Qiaoyuan Co., Ltd. (301286) closed at 44.92, up 16.89% with a trading volume of 116,300 shares and a transaction value of 496 million [1] - Huahua Co., Ltd. (003002) closed at 29.43, up 6.90% with a trading volume of 98,700 shares and a transaction value of 287 million [1] - Liansheng Chemical (301212) closed at 30.31, up 6.43% with a trading volume of 39,000 shares and a transaction value of 116 million [1] - Hangzhou Hydrogen Co., Ltd. (002430) closed at 30.58, up 6.25% with a trading volume of 338,400 shares and a transaction value of 1.019 billion [1] - China General Nuclear Power Technology (000881) closed at 9.02, up 5.87% with a trading volume of 710,400 shares and a transaction value of 638 million [1] Top Losers in Chemical Sector - Letong Co., Ltd. (002319) closed at 10.50, down 10.03% with a trading volume of 50,900 shares and a transaction value of 53.96 million [2] - Quanliang Zero (002407) closed at 29.44, down 8.09% with a trading volume of 1,946,300 shares and a transaction value of 5.76 billion [2] - Yongtai Technology (002326) closed at 22.02, down 7.21% with a trading volume of 926,100 shares and a transaction value of 2.073 billion [2] Fund Flow Analysis - The chemical products sector experienced a net outflow of 932 million from institutional investors, while retail investors saw a net inflow of 742 million [2] - The top stocks with significant fund flow include ST Jiaao (603822) with a net inflow of 99.67 million from institutional investors [3] - Other notable stocks include Meihua Biological (600873) with a net inflow of 52.33 million and Hangzhou Oxygen (002430) with a net inflow of 39.94 million from institutional investors [3]

证券之星消息，12月2日化学制品板块较上一交易日下跌0.95%，*ST金泰领跌。当日上证指数报收于 3897.71，下跌0.42%。深证成指报收于13056.7，下跌0.68%。化学制品板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603683 | 晶华新材 | 28.35 | 4.81% | 22.90万 | | 6.43亿 | | 300200 | 高盟新材 | 12.82 | 3.81% | 96.58万 | | 12.27亿 | | 603334 | 丰倍生物 | 45.20 | 3.06% | 4.62万 | | 2.07亿 | | 603822 | 嘉澳环保 | 84.81 | 2.68% | - 2.69万 | | 2.27亿 | | 002453 | 华软科技 | 6.99 | 2.34% | 103.86万 | | ...